FdaApplication
ANDA 206204
Identifiers
- fda_app_no: ANDA206204
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2018-05-11 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | EQ 12GM BASE/VIAL;EQ 1.5GM BASE/VIAL | INJECTABLE;INJECTION |
1 product